Medicine News and Research

RSS

CIDR utilizes Isilon scale-out NAS for genotyping and statistical genetics services

Isilon Systems today announced that the Center for Inherited Disease Research (CIDR) at Johns Hopkins University is using Isilon scale-out NAS to power its leading-edge genotyping and statistical genetics services, which generate up to three terabytes of new data per day.

9 Dec 2009

Preliminary data from Phase 2 clinical trial of ZFP Therapeutic program presented

Sangamo BioSciences, Inc. announced today the presentation of preliminary data from the Phase 2 clinical trial of its ZFP Therapeutic(TM) program to develop SB-509 as a treatment for amyotrophic lateral sclerosis (ALS) at a Work in Progress session at the 20th International Symposium on ALS/MND held in Berlin, Germany.

9 Dec 2009

Risk of serious injury at summer camps is low compared to other popular youth activities

Although a trip to summer camp is highly anticipated by over 11 million children and adults each year, sending a child off to summer camp can be a source of anxiety for parents. Findings from a new study published in the December issue of Injury Prevention should ease their concerns however.

9 Dec 2009

2009 Ward Burdick Award for UAB Director

The director of the University of Alabama at Birmingham (UAB) Center for Metabolic Bone Disease has won the 2009 Ward Burdick Award for Distinguished Service to Clinical Pathology from the American Society for Clinical Pathology (ASCP).

9 Dec 2009

Laser technique used to change metal colors could have important implications for medicine

University of Rochester optics professor Chunlei Guo made headlines in the past couple of years when he changed the color of everyday metals by scouring their surfaces with precise, high-intensity laser bursts.

9 Dec 2009

Human blood stem cells can be engineered to kill HIV and other chronic viral diseases

Researchers from the UCLA AIDS Institute and colleagues have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells - a process that potentially could be used against a range of chronic viral diseases.

9 Dec 2009

Recruitment complete in Oxagen's OC000459 IIb clinical trial for asthma

Oxagen Limited, a drug discovery and development company specializing in inflammation, today announced that the recruitment for its double blind, randomised, placebo controlled Phase IIb clinical trial in asthma with OC000459, its lead oral CRTH2 (DP2) antagonist, has now been completed.

9 Dec 2009

Report highlights the state of oral health for children and adults in the United States

Oral disease, primarily dental caries, is the most common pediatric disease and can lead to physical and psychological disabilities as well as significant morbidity in adulthood.

9 Dec 2009

Research article on Peliosis hepatis

Peliosis hepatis (PH) is a rare pathological entity. PH varies from minimal asymptomatic lesions to larger massive lesions that may present with cholestasis, liver failure, portal hypertension, avascular mass lesion, or even spontaneous rupture.

9 Dec 2009

New Acesis software platform improves patient safety and quality care

Acesis, the enterprise software company focused on healthcare performance improvement, today announced results from its first six months of service for the University of California, San Francisco (UCSF) Division of Hospital Medicine.

9 Dec 2009

Vestagen Technical Textiles introduces Nanotechnology-Based Healthcare Specialty Textiles

Vestagen Technical Textiles today announced its entry into the advanced performance textile arena with the introduction of the first of a new class of Nanotechnology-Based Healthcare Specialty Textiles.

9 Dec 2009

GPEC receives unrestricted grant of $250,000 to study new treatments for breast cancer

Located at Vancouver General Hospital and a partner of the BC Cancer Agency, the Genetic Pathology Evaluation Centre, led by three prominent pathologists, is a recognized world leader in cancer research in the area of biomarker technology. Today, with an additional unrestricted grant of $250,000 from sanofi-aventis, GPEC is ready to make even more scientific breakthroughs.

9 Dec 2009

LCA and national organizations join hands to address lung cancer

Today, Lung Cancer Alliance (LCA) praised the growing coalition of national organizations joining LCA in its "call to action" to devise a better public health strategy to address the nation's most lethal cancer.

9 Dec 2009

Experts call on Europe's policy makers to take urgent action against preventable strokes

A report launched today by experts from medical and patient communities calls on Europe's policy makers to take urgent action against preventable strokes that strike thousands of atrial fibrillation (AF) patients each year

9 Dec 2009

Researchers describe how PDNF protein prolongs the life of T. cruzi parasite

The parasite Trypanosoma cruzi (or T. cruzi), which causes Chagas' disease, will go to great lengths to evade death once it has infected human host cells, researchers have discovered. In a study published in the November 17 online issue of Science Signaling, the researchers describe how a protein called parasite-derived neurotrophic factor (PDNF) prolongs the life of the T. cruzi parasite by activating anti-apoptotic (or anti-cell-death) molecules in the host cell. These protective mechanisms help to explain how host cells continue to survive despite being exploited by T. cruzi parasites.

9 Dec 2009

People living in deprived neighborhoods more likely to die from cancer and heart disease

Regardless of an individual's dietary and lifestyle risk factors, living in a poorer or more socioeconomically deprived neighborhood may increase a person's risk for death, according to data presented at the American Association for Cancer Research Conference on Frontiers in Cancer Prevention Research, held Dec. 6-9, 2009.

9 Dec 2009

Smokers taking the Respiragene test try to quit smoking, reveals study

Smokers who see their own personal risk of developing lung cancer after genetic-based testing show stronger intention and take more action on quitting smoking, according to clinical trial results presented to an American Association of Cancer Research conference.

9 Dec 2009

Depression drug TC-5214 earns USF its most lucrative patent royalties to date

A depression drug created and patented by a team of University of South Florida researchers is at the center of major deal between global pharmaceutical company AstraZeneca PLC and Targacept, Inc., earning the university its potentially most lucrative patent royalties to date.

9 Dec 2009

State and national medical societies join to oppose the 'Patient Protection and Affordable Care Act'

Tens of thousands of physicians in America, who are deeply concerned over the direction of health reform legislation, have joined forces to deliver a strong message to Congress: it’s not too late to get it right; slow down and change course.

9 Dec 2009

New article in Women's Health journal emphasizes the importance of early pregnancy detection

A new article published in the peer-reviewed journal Women's Health emphasizes the importance of early pregnancy detection. Using research conducted on behalf of Church & Dwight Co. Inc., the makers of First Response, the article reviews data that shows not all at-home pregnancy tests are created equal -First Response brand pregnancy tests are more sensitive and able to detect key variants of the pregnancy hormone better than other at home pregnancy tests.

9 Dec 2009

Medicine News and Research

CIDR utilizes Isilon scale-out NAS for genotyping and statistical genetics services

Preliminary data from Phase 2 clinical trial of ZFP Therapeutic program presented

Risk of serious injury at summer camps is low compared to other popular youth activities

2009 Ward Burdick Award for UAB Director

Laser technique used to change metal colors could have important implications for medicine

Human blood stem cells can be engineered to kill HIV and other chronic viral diseases

Recruitment complete in Oxagen's OC000459 IIb clinical trial for asthma

Report highlights the state of oral health for children and adults in the United States

Research article on Peliosis hepatis

New Acesis software platform improves patient safety and quality care

Vestagen Technical Textiles introduces Nanotechnology-Based Healthcare Specialty Textiles

GPEC receives unrestricted grant of $250,000 to study new treatments for breast cancer

LCA and national organizations join hands to address lung cancer

Experts call on Europe's policy makers to take urgent action against preventable strokes

Researchers describe how PDNF protein prolongs the life of T. cruzi parasite

People living in deprived neighborhoods more likely to die from cancer and heart disease

Smokers taking the Respiragene test try to quit smoking, reveals study

Depression drug TC-5214 earns USF its most lucrative patent royalties to date

State and national medical societies join to oppose the 'Patient Protection and Affordable Care Act'

New article in Women's Health journal emphasizes the importance of early pregnancy detection

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News